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Background
Due to a lack of sufficiently accurate and effective tools,
allergy is often badly diagnosed. Moreover, its treatment is
expensive, long, uncomfortable and of little effectiveness.
In this context, less than a quarter of allergic patients
receive a treatment currently. Allergies have therefore
become an important public health issue, highlighting the
many unmet medical needs. ANGANY Genetics has
brought together expertise in protein genomics and in
therapeutic protein production in plant expression sys-
tems, to produce recombinant allergens of an unprece-
dented quality, offering the following solutions to allergy
sufferers: (1) a precise identification of each allergen
involved rather than the current approximate diagnosis,
(2) pure and certified recombinant allergens rather than
imperfect and incomplete allergen extracts and (3) an
effective treatment at the best cost to replace sympto-
matic-only or low-level curative allergy treatments.
Method
In this context, ANGANY Genetics has developed Aller-
goPur™ for production of high quality natural-like recom-
binant allergens needed for high efficiency of allergy
treatment. AllergoPur™ is a plant-based production plat-
form using transient expression in N. benthamiana. This
strategy offers a rapid, flexible and high-yielding produc-
tion of recombinant allergens. Typically, high rates of
recombinant allergens can be recovered twelve days after
gene delivery. Furthermore, in contrast to bacterial cells,
plants can produce recombinant allergens that require
complex post-translational modifications and, obviously,
plants are also the best system for expression of plant
allergens requiring plant-specific maturations.
Results
Using AllergoPur™, ANGANY Genetics has already pro-
duced high quality recombinant allergens from mites, pol-
lens, mammals or mold. This is illustrated here with eight
recombinant allergens required for an accurate diagnosis
and an efficient immunotherapy of dust mite allergy. The
detailed biological and structural characterizations of these
recombinant allergens illustrate their quality and confor-
mity to natural products.
Conclusion
AllergoPur™ is a powerful tool for the rapid production
of high quality natural like recombinant allergens. The
capacity of this platform is illustrated with the successful
expression of complex allergens impossible to produce in
prokaryotic systems, such as Der p 1 or Hev b 13. Some
of these allergens are currently tested in preclinical
studies.
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